首页> 外国专利> New antimicrobial peptides isolated from hemolymph of butterfly larvae, useful for control of bacterial and fungal infections in human and veterinary medicine and for generating plants resistant to bacterial and fungal infections

New antimicrobial peptides isolated from hemolymph of butterfly larvae, useful for control of bacterial and fungal infections in human and veterinary medicine and for generating plants resistant to bacterial and fungal infections

机译:从蝴蝶幼虫的淋巴中分离出的新型抗菌肽,可用于控制人类和兽医学中的细菌和真菌感染,并产生对细菌和真菌感染具有抵抗力的植物

摘要

Antimicrobial peptides (I), and their derivatives and fragments, are new. Antimicrobial peptides of sequence (I), and their derivatives and fragments, are new. X1-Lys-Ile-Pro-X2-Ala-X3-Lys-Gly-Ala-X4-Arg-Ala-Leu-X5-Ala-Ser-Thr-Ala-X6- Asp-Ile-Ala-X6-Phe-X8-Arg-Lys-Arg-X9 (I) X1 = amino, Arg or Gly; X2 = Ile-Asn or Val-Glu; X3 = Ile-Lys, Ile-Arg or Leu-Lys; X4 = Ser-Arg-Ala-Trp, Lys-Ala-Val-Gly-His-Gly-Leu or Lys-Val-Ala-Gly-Arg-Ala-Trp; X5 = Asp-Leu, Asn-Ile or Asp-Leu; X6 = Tyr or His; X7 = Ser-Ile, Ser-Ala or His-Leu; X8 = Asn, Asp or His; and X9 = hydroxy, Glu, Asn or Lys-His. Independent claims are also included for: (1) polypeptide (II) that includes (I); (2) isolated polynucleotide (III) that encodes (I) or (II), also sequences (IIIa) that hybridize to (III); (3) chimeric gene (CG) comprising (III) or (IIIa) linked to a constitutive or inducible promoter and to a terminator; (4) expression and/or cloning vector that contains (III), (IIIa) or CG; (5) host organism that contains the vector of (4); and (6) plant cell, or plant, that is resistant to bacterial and/or fungi and contains (III), (IIIa) or CG, for expression of (I) or (II).
机译:抗菌肽(I)及其衍生物和片段是新的。序列(I)的抗菌肽及其衍生物和片段是新的。 X1-Lys-Ile-Pro-X2-Ala-X3-Lys-Gly-Ala-X4-Arg-Ala-Leu-X5-Ala-Ser-Thr-Ala-X6-Asp-Ile-Ala-X6-Phe- X8-Arg-Lys-Arg-X9(I)X1 =氨基,Arg或Gly; X2 = Ile-Asn或Val-Glu; X3 = Ile-Lys,Ile-Arg或Leu-Lys; X4 = Ser-Arg-Ala-Trp,Lys-Ala-Val-Gly-His-Gly-Leu或Lys-Val-Ala-Gly-Arg-Ala-Trp; X5 = Asp-Leu,Asn-Ile或Asp-Leu; X6 =提尔或他的; X7 = Ser-Ile,Ser-Ala或His-Leu; X8 = Asn,Asp或His;和X 9 =羟基,Glu,Asn或Lys-His。还包括以下方面的独立权利要求:(1)包括(I)的多肽(II); (2)分离的编码(I)或(II)的多核苷酸(III),以及与(III)杂交的序列(IIIa); (3)嵌合基因(CG),其包含与组成型或诱导型启动子和终止子连接的(III)或(IIIa); (4)含有(III),(IIIa)或CG的表达和/或克隆载体; (5)含有(4)的载体的宿主生物; (6)对细菌和/或真菌具有抗性并含有(III),(IIIa)或CG的植物细胞或植物,用于表达(I)或(II)。

著录项

  • 公开/公告号FR2843591A1

    专利类型

  • 公开/公告日2004-02-20

    原文格式PDF

  • 申请/专利权人 ENTOMED;

    申请/专利号FR20020010278

  • 发明设计人 MEYER JEAN PHLIPPE;

    申请日2002-08-13

  • 分类号C07K14/435;C12N15/12;C12N15/63;A61K38/17;A61P31/00;A01H5/00;A01N37/18;

  • 国家 FR

  • 入库时间 2022-08-21 22:39:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号